MagnestisMM: Key Efficacy Data and its Clinical Implications

In this segment, Dr. Mohan asks Dr. Mann to summarize the key efficacy data from the MagnestisMM trials evaluating the use of elranatamab in relapsed/refractory multiple myeloma (R/R MM).

EP: 1.John’s Journey with R/R MM

EP: 2.MonumenTAL: Key Efficacy Outcomes

EP: 3.Implications of Talquetamab on the Current Treatment Landscape for R/R MM

EP: 4.Bispecifics in R/R MM: Selecting the Best Bispecific and Optimal Sequencing Strategies

EP: 5.Eva’s Treatment Journey With R/R MM

Now Viewing

EP: 6.MagnestisMM: Key Efficacy Data and its Clinical Implications

Video content above is prompted by the following:

Can you summarize the key efficacy data from the MagnestisMM trials evaluating the use of elranatamab in R/R MM?

Recent Videos